Search
for
Sort by
Research 31–60 of 731
- A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- An Evaluation System to Enhance Patient Selection for Alopecia-Reducing Surgery
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Ovarian Hypertension: Polycystic Ovary Syndrome
- PCOS in lesbian and heterosexual women treated with artificial donor insemination
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- May AMH levels distinguish LOCAH from PCOS among hirsute women?
- 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- An Evaluation System to Enhance Patient Selection for Alopecia-Reducing Surgery
- Alopecia y tratamientos láser. Una revisión de la literatura
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Adverse events of dual anti-seizure medication: Real-life data from a tertiary epilepsy clinic
- Survey on adverse events associated with drug therapy for breast cancer patients
- Simplify your approach to the diagnosis and treatment of PCOS
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system